Skip to main content
Premium Trial:

Request an Annual Quote

Tim Yeaton, Peter Hraber

Premium

Tim Yeaton has been named CEO of Avaki. Yeaton joined Avaki in 2001 as COO, and was most recently president of the company.


Peter Hraber has joined Exagen Diagnostics as a research scientist and computational biologist. Hraber will be responsible for implementing the company’s computational engine for genomic data analysis, Exagen said.

Filed under

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.